The Journal of Headache and Pain Study On Migraine
The Journal of Headache and Pain recently announced the results of a study, according to that migraine is the leading cause of days lost due…
Migraine
Patients With Migraine And COVID-19 Pandemic
Since the declaration COVID-19 as a pandemic, healthcare systems around the world have faced a huge challenge in managing patients with chronic diseases, including patients…
Impel Neuropharma Acute Migraine Treatment
Recently Impel NeuroPharma Announces FDA (The Food and Drug Administration) submission of a new drug application for INP104 for the acute treatment of migraine. INP104…